etoposide has been researched along with xr5944 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baguley, BC; Baker, M; Bootle, D; Charlton, PA; Dangerfield, W; Denny, WA; Kofler, B; Mistry, P; Okiji, S; Stewart, AJ | 1 |
| Charlton, PA; Coley, HM; Lewis, LJ; Mistry, P; Thomas, H | 1 |
2 other study(ies) available for etoposide and xr5944
| Article | Year |
|---|---|
Antitumor activity of XR5944, a novel and potent topoisomerase poison.
Topics: Aminoquinolines; Animals; Antigens, Neoplasm; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Colonic Neoplasms; DNA; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA-Binding Proteins; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Indenes; Inhibitory Concentration 50; Injections, Intraperitoneal; Injections, Intravenous; Isoenzymes; Lung Neoplasms; Mice; Mice, Nude; Phenazines; Remission Induction; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Topotecan; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2001 |
Mode of action of the novel phenazine anticancer agents XR11576 and XR5944.
Topics: Annexin A5; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; ATP-Binding Cassette Transporters; bcl-X Protein; Blotting, Western; Camptothecin; Caspase 9; Cell Cycle; Cell Line, Tumor; DNA, Neoplasm; Drug Resistance, Neoplasm; Etoposide; Humans; Indicators and Reagents; Neoplasm Proteins; Phenazines; Topoisomerase I Inhibitors | 2007 |